KAMADA » MEDIA » UPCOMING EVENTS

UPCOMING EVENTS

Upcoming Events

Kamada will host a Research and Development Day to highlight Graft versus Host Disease (GvHD)

Mar. 3, 2017 / New York

Kamada will host a Research and Development Day to highlight Graft versus Host Disease (GvHD) in New York City on March 3 from 12:00pm to 1:30pm Eastern Time.

This event is intended for institutional investors, sell-side analysts, investment bankers, and business development professionals only.  Please RSVP in advance if you plan to attend, as space is limited. To reserve a spot, please reply to this email or contact LifeSci Advisors, LLC at Mac@LifeSciAdvisors.com.  A live and archived webcast of the event, with slides, will be available at http://lifesci.rampard.com/20170303/reg.jsp.

The meeting will feature a presentation by key opinion leaders H. Joachim Deeg, MD (Fred Hutchinson Cancer Research Center) and David M. Gelmont, MD (formerly at Shire/Baxalta), who will discuss the current treatment landscape for GvHD in bone marrow transplant patients and the unmet medical need for patients who develop acute GvHD. Both KOLs will be available to answer questions following the lunch.

Kamada management will provide an overview of the Company’s ongoing clinical development work with their liquid form of Alpha-1 Antitrypsin (AAT) to treat acute Graft versus Host Disease, including published data to-date, and the company's clinical strategy moving forward.

Kamada to participate in PPTA Congress, Prague 2017

Mar. 14-15, 2017

Every year, policymakers, regulators, industry leaders, physicians, scientists, and patient representatives from around the globe come together for the plasma protein therapeutics industry's premier European event—the International Plasma Protein Congress (IPPC).

Kamada to participate in 3rd International Research Conference on Alpha-1 Antitrypsin and 6th Alpha-1 Global Patient Congress

Apr. 5-8, 2017 / Lisbon, Portugal

The Alpha-1 global mission is to develop a collaborative global network of Alpha-1 patient leaders, physicians, and researchers, to increase awareness, detection, and access to care for Alphas around the world.


Past Events

Kamada to Host Fiscal Year 2016 Financial Results Conference Call on February 6

Feb. 2, 2017 / Conference Call

Direct webcast link

Kamada  announced today that it will release financial results for the fiscal year ended December 31, 2016 prior to the open of the U.S. financial markets on Monday, February 6, 2017.
Kamada management will host an investment community conference call on Monday,
February 6 at 8:30 a.m. Eastern time to discuss these results and answer questions.
Shareholders and other interested parties may participate in the conference call by dialing
888-452-4034 (from within the U.S.), 1 80 924 5905 (from Israel), or 719-457-2087
(International) and entering the conference identification number: 5468241. The call will
also be webcast live on the internet on the Company’s website at www.kamada.com.
A replay of the call will be accessible two hours after its completion through February 20
by dialing 844-512-2921 (from within the U.S.) or 412-317-6671 (from outside the U.S.)
and entering the conference identification number: 5468241. The call will also be archived
for 90 days on the Company’s website at www.kamada.com.

Kamada to participate in J.P. Morgan 35th Annual Healthcare Conference 2017 San Francisco

Jan. 9-12, 2017

J.P. Morgan is a global leader in financial services, offering solutions to the world's most important corporations, governments and institutions in more than 100 countries. The Firm and its Foundation give approximately US$200 million annually to nonprofit organizations around the world. They also lead volunteer service activities for employees in local communities by utilizing their many resources, including those that stem from access to capital, economies of scale, global reach and expertise.

Kamada to participate in 58th the ASH Annual Meeting

Dec. 3-6, 2016

The ASH Annual Meeting is the world's premier event in malignant and non-malignant hematology. The meeting provides an invaluable educational experience and an opportunity to review thousands of scientific abstracts highlighting updates in the hottest topics in hematology.

Kamada to participate in Jefferies 2016 London Healthcare Conference

Nov. 16-17, 2016 / London, UK

The Jefferies Conference is the largest healthcare-dedicated conference in Europe. The event will feature leading public and private companies from the pharmaceuticals, biotechnology, generics, consumer health, animal health, medical technology and healthcare services sectors from the United States, Europe, Africa, Middle East, Latin America, Russia, India, Israel, China and Japan.

The two-day event will include concurrent tracks of company presentations, thematic panel discussions, and 1x1/small-group meetings. This global gathering of leading healthcare executives and institutional, private equity and venture capital investors will address near- and long-term investment opportunities and discuss the mechanisms driving global healthcare.

Kamada to Host Third Quarter and 2016 Financial Results Conference Call

Nov. 10, 2016 / Conference Call

Direct webcast link: http://public.viavid.com/index.php?id=121501

Kamada management will host an investment community conference call today, Thursday, November 10, 2016 at 8:30 a.m. Eastern time to discuss these results and answer questions. Shareholders and other interested parties may participate in the conference call by dialing 888-487-0346 (from within the U.S.), 1 80 924 5905 (from Israel) and entering the conference identification number: 606-3325. The call will also be webcast live on the internet on the Company’s website at www.kamada.com.

A replay of the call will be accessible two hours after its completion through November 24, 2016 by dialing 844-512-2921 (from within the U.S.) or 412-317-6671 (from outside the U.S.) and entering the conference identification number: 606-3325. The call will also be archived for 90 days on the Company’s website at www.kamada.com.

kamada to participate in the Bio-Europe conference

Nov. 7-9, 2016 / Cologne, Germany

BIO-Europe is Europe's largest partnering conference serving the global biotechnology industry.

Rodman & Renshaw 18th Annual Global Investment Conference

Sep. 11-13, 2016 / Lotte New York Palace Hotel

This year’s conference will bring growth companies together with a vast audience of financial and strategic investors. In addition to corporate presentations, Rodman facilitates one-on-one investor meetings and provides platforms for engaged Q&A sessions. 

The conference will focus on tracks dedicated to Healthcare; Natural Resources; Technology,
Media and Telecommunications; Cleantech

ERS International Congress 2016

Sep. 3-7, 2016 / London, United Kingdom

The Congress Scientific programme will present the best in science and educational sessions from distinguished researchers from across the globe. Covering key topics in respiratory medicine from across the spectrum of disease areas including TB, lung cancer, pneumonia, cystic fibrosis, COPD, and asthma amongst others, the Congress is the best place to build skills and knowledge through hearing the latest topics in the field.

IATI Biomed 2016

May. 24-26, 2016 / Tel Aviv, Israel

This year, as we mark our 15th anniversary, we are excited to introduce a new format in which we will explore and aim to fuel the innovations and trends that are shaping the future of healthcare systems and life sciences.

ATS- International Conference 2016

May. 13-18, 2016 / San Francisco, California

The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders. Founded in 1905 to combat TB, the ATS has grown to tackle asthma, COPD, lung cancer, sepsis, acute respiratory distress, and sleep apnea, among other diseases.

First Quarter Financial Results Conference Call

May. 9, 2016 / Conference call

Link to webcast

Kamada management will host an investment community conference call on Monday, May 9, 2016 at 8:30 a.m. Eastern time to discuss these results and answer questions.  Shareholders and other interested parties may participate in the conference call by dialing 888-803-5993 (from within the U.S.), 706-634-5454 (from outside the U.S.) and entering the conference identification number: 5573974. The call will also be webcast live on the internet on the Company’s website at www.kamada.com

A replay of the call will be accessible two hours after its completion through May 15, 2016 by dialing 855-859-2056 (from within the U.S.) or 404-537-3406 (from outside the U.S.) and entering the conference identification number: 5573974. The call will also be archived for 90 days on the Company’s website at www.kamada.com

Bio Europe Spring 2016

Apr. 4-6, 2016 / Stockholm - Sweden

BIO-Europe Spring® is the premier springtime partnering conference which annually attracts an international "who's who" from biotech, pharma and finance for three days of high caliber networking.

International Plasma Protein Congress

Mar. 22-23, 2016 / Barcelona - Spain

The IPPC is the premier conference in Europe for the plasma protein therapeutics industry. Take advantage of this event and join policy makers, regulators, industry leaders, physicians, scientists, and patient representatives from around the globe.

Kamada to Present at Source Capital Group’s 2016 Disruptive Growth & Healthcare Conference

Feb. 10 - Jan. 11, 2016 / New-York City, USA

NESS ZIONA, Israel (February 5, 2016) – Kamada Ltd. (NASDAQ and TASE: KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announced today that the Company will participate at the Source Capital Group’s 2016 Disruptive Growth & Healthcare Conference taking place February 10-11, 2016 in New York City.  Amir London, the Company’s Chief Executive Officer, will present a corporate overview on February 11th from 12:30PM to 12:55PM.

Mr. London’s slide presentation will be available on the Company’s website at www.kamada.com

The 18th Annual BIO CEO & Investor Conference 2016

Feb. 8-9, 2016 / Astoria New York - USA

Each year the BIO CEO & Investor Conference provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry.

The conference features issue-oriented plenary sessions, educational sessions focused on hot therapeutic areas and key business issues, company presentations, one-on-one meetings, and networking opportunities.

Our therapeutic workshops feature MDs, CSOs and industry analysts discussing the latest information on pipeline innovation for breakthrough therapeutic topics in biopharma. Seasoned industry executives and analysts delve into timely and relevant business models, deal-making and investment trends on our business roundtables.

Kamada to Host Fourth Quarter and Year End 2015 Financial Results Conference Call

Feb. 2, 2016

NESS ZIONA, Israel (January 27, 2016) – Kamada Ltd. (NASDAQ and TASE: KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces that it will release financial results for the three and twelve months ended December 31, 2015 prior to the open of the U.S. stock market open on Tuesday, February 2, 2016. 

Kamada management will host an investment community conference call on Tuesday, February 2, 2016 at 8:30 a.m. Eastern time to discuss these results and answer questions.  Shareholders and other interested parties may participate in the conference call by dialing 888-803-5993 (from within the U.S.), 706-634-5454 (from outside the U.S.) or 1-809-315-362 (toll-free from Israel) and entering the conference identification number: 38830870. 

The call will also be webcast live here.

A replay of the call will be accessible two hours after its completion through February 8, 2016 by dialing 855-859-2056 (from within the U.S.) or 404-537-3406 (from outside the U.S.) and entering the conference identification number: 38830870. 

J.P. Morgan 34th Annual Healthcare Conference

Jan. 11-15, 2016 / San Francisco, CA, USA.

J.P. Morgan conferences bring together corporate leaders, financial sponsors and institutional investors to explore market and sector trends. 

Kamada to participate at the Bio Europe Spring Conference

Mar. 9-11, 2015 / Paris, France

About the Bio Europe Spring Conference, where the global biotech industry comes to partner.

BIO-Europe Spring® is the springtime counterpart to EBD Group’s flagship conference, BIO-Europe®, and continues the tradition of providing life science companies with high caliber partnering opportunities.

Kamada to participate at the 33rd J.P. Morgan Annual Healthcare Conference January 2015

Jan. 12-15, 2015 / San Francisco

The 33rd Annual J.P. Morgan Healthcare Conference & Biotech Showcase 2015 will be held January 12-15, 2014 in San Francisco, California.

The Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences.

Investors and biopharmaceutical executives from around the world gather in San Francisco during this critical week which is widely viewed as setting the tone for the coming year.

- See more at: http://globalbiodefense.com/event/j-p-morgan-annual-healthcare-conference/#sthash.fHzinGct.dpuf

Kamada to present at the Jefferies 2013 London Healthcare Conference

Nov. 20-21, 2013 / London, England

The 2013 conference is set to feature public and private leading global healthcare companies within the areas of pharmaceuticals, biotech, generics, medtech and healthcare services from the US, Central and Eastern Europe, Latin America, India, China, Japan, Egypt, Israel and Russia.

This global gathering of institutional investors, private equity investors, VCs and leading executives will address near- and long-term investment opportunities and discuss the mechanisms driving global healthcare.

Financial Third Quarter 2013 Results Conference Call

Oct. 29, 2013 / Conference call

Kamada management will host an investment community conference call on Tuesday, October 29, 2013 beginning at 8:30 a.m. Eastern time to discuss these results and answer questions.  Shareholders and other interested parties may participate in the conference call by dialing 888-803-5993 (from within the U.S.) or 706-634-5454 (from outside the U.S.) or 1-809-315-362 (toll-free from Israel) and entering passcode 87555865. The call also will be broadcast live on the Internet at www.streetevents.com, www.earnings.com and www.kamada.com.

A replay of the conference call will be accessible two hours after its completion through November 4, 2013 by dialing (855) 859-2056 (from within the U.S.) or (404) 537-3406 (from outside the U.S.) and entering passcode 87555865. The call will also be archived for 90 days at www.streetevents.com, www.earnings.com and www.kamada.com.

Kamada to participate at the ERS annual congress

Sep. 7-11, 2013 / Barcelona, Spain

Kamada will host an investment community conference call

Aug. 1, 2013

Kamada management will host an investment community conference call on 1.8.2013, beginning at 10:00 a.m. Eastern time to discuss Q2 results and answer questions.  Shareholders and other interested parties may participate in the conference call by dialing (888) 803-5993 (from within the U.S.) or (706) 634-5454 (from outside the U.S.) and entering passcode 21054403. The call also will be broadcast live on the Internet at www.streetevents.com, www.earnings.com and www.kamada.com.

Kamada to participate at the PPTA's 2013 Plasma Protein Forum

Jun. 11-12, 2013 / Virginia, USA
People worldwide rely on access to plasma-derived and recombinant analog therapies to improve and save their lives, and this is an opportunity for all stakeholders to come together. Consumers, physicians, caregivers, regulators and policymakers, and industry representatives should attend. Key issues facing the industry today and in the future will be presented.

Kamada to speak at the 2013 IATI- Biomed confrence in Israel

Jun. 10-12, 2013 / Tel Aviv, Israel

IATI BIOMED 2013 follows the success of previous annual conferences where the Israeli Life Sciences industry hosted 6,000 industry players, engineers and scientists with approximately 1,000 participants from over 40 countries and in excess of 3,500 one-on-one meetings.

Kamada's presentation, on new clinical developments for Alpha-1 Antitrypsin, will take place at June 10, 4:50pm.

Kamada to participate at the 22nd Alpha-1 patients national education conference in Washington

Jun. 7-9, 2013 / Washington, D.C, USA

 The National Conference is the largest gathering of Alphas and families in the world, with an expected attendance of more than 600 people,

Kamada to participate at the American Thoracic Society International Conference

May. 16-21, 2013 / Philadelphia

The annual International Conference of the American Thoracic Society is one of the largest gatherings of pulmonary, critical care and sleep clinicians and researchers in the world.

Kamada to participate at the International Plasma Protein Congress (IPPC)

Mar. 4-5, 2013 / Dublin, Ireland

IPPC is the primary international congress for all stakeholders of plasma protein therapies.
Sessions will feature topics such as clinical developments, patient access, self-sufficiency, regulatory considerations, plasma collection, health policy and much more.

Kamada to participate at the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Paris

Feb. 26 - Mar. 1, 2013 / Paris, France

ATTD 2013 is an innovative conference that will bring together the world’s leading researchers and clinicians for a lively exchange of ideas and information related to the treatment and prevention of diabetes and related illnesses.

Kamada to receive the Title of Outstanding Exporter from Israel’s President, Shimon Peres

Jan. 6, 2013 / Jerusalem

The Israeli President will presents the outstanding exporter award to Kamada on its performance in 2011.

Kamada to participat at Deloitte's Technology Fast 50

Oct. 15, 2012

The Deloitte Brightman Almagor Zohar Technology Fast 50 Program annually recognizes and honors the 50 private and publicly held fastest growing technology companies in Israel, based on percentage revenue growth over a five-year period.

Kamada to participate at the ERS annual congress in Vienna

Aug. 31 - Sep. 4, 2012 / Vienna, Austria